Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-15

Clinical Trial Update: Vitamin D for Prostate Endocrine Therapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating vitamin D as an adjunct to prostate endocrine therapy is currently recruiting across stages I–IVA prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: University of Rochester | Conditions: Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 | Phase 3 | Status: RECRUITING